Coya Therapeutics
COYA
14 hedge funds and large institutions have $5.5M invested in Coya Therapeutics in 2023 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
100% more funds holding
Funds holding: 7 → 14 (+7)
26% more capital invested
Capital invested by funds: $4.37M → $5.5M (+$1.13M)
2.51% more ownership
Funds ownership: 11.07% → 13.59% (+2.5%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CM
CM Management
Gulf Breeze,
Florida
|
+$278K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$272K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$214K |
| 4 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$125K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$110K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$1.36K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ACM
1
AIGH Capital Management
Baltimore,
Maryland
| $2.39M | +$125K | +26,872 | +5% |
|
|
GC
2
Greenlight Capital
New York
| $1.6M | – | – | – |
|
|
WVP
3
Worth Venture Partners
Fort Lee,
New Jersey
| $596K | +$40.5K | +8,735 | +6% |
|
|
CM
4
CM Management
Gulf Breeze,
Florida
| $244K | +$278K | +60,000 | New |
|
|
5
Geode Capital Management
Boston,
Massachusetts
| $238K | +$272K | +58,573 | New |
|
|
6
Bank of America
Charlotte,
North Carolina
| $187K | +$214K | +46,052 | New |
|
|
7
UBS Group
Zurich,
Switzerland
| $108K | +$110K | +23,756 | +835% |
|
|
MCP
8
Mirador Capital Partners
Pleasanton,
California
| $62.5K | +$71.3K | +15,361 | New |
|
9
Citadel Advisors
Miami,
Florida
| $42.9K | +$48.9K | +10,537 | New |
|
|
10
BlackRock
New York
| $30.3K | -$1.36K | -294 | -4% |
|
|
TWM
11
Tradition Wealth Management
Edina,
Minnesota
| $3K | – | – | – |
|
12
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | +$705 | +152 | New |
|
13
Morgan Stanley
New York
| $814 | +$928 | +200 | New |
|
14
Wells Fargo
San Francisco,
California
| $94 | +$5 | +1 | +5% |
|
COYA Hedge Fund Activity: Q2 2023 in Review
14 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Coya Therapeutics (COYA) for Q2 2023, worth a combined $5.5M — up 26% from $4.37M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new COYA positions and 0 closed out — a net gain of 7 holders — while 4 added to existing stakes and 1 trimmed.
The largest buyer was CM Management, opening a new position worth an estimated $278K. The largest seller was BlackRock, cutting an estimated $1.36K.
- 14 institutional investors held Coya Therapeutics (COYA) as of Q2 2023, up from 7 in Q1 2023.
- Funds reported $5.5M of Coya Therapeutics stock for Q2 2023, up 26% quarter-over-quarter.
- 7 funds opened new Coya Therapeutics positions in Q2 2023 and 0 closed out, a net change of +7 holders.
- The largest Coya Therapeutics buyer in Q2 2023 was CM Management, an estimated $278K added.
- The largest Coya Therapeutics seller in Q2 2023 was BlackRock, an estimated $1.36K sold.
Based on aggregated 13F filings for Q2 2023.